Health Care · Pharmaceutical Preparations · NYSE · CIK 1551152 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $265.97 · Day +2.72% · Mkt cap $457.5B · P/E (FY) 109.7× · 1Y +32.1% · Off 52W high −0.6% · Vol (1Y) 26.4% Price2023-08-21 → 2026-08-19 ABBV close: $150 on 2023-08-21 to $266 on 2026-08-19. Split-adj closes · 240 of 3,441 · price returnⓘ At a glance | Short interest1.3% of sh out | | Days to cover4.0d | | 13F net flow (QoQ)−0.01% | | Top-10 13F concentration47.3% | | Next report (est.)2026-11-01 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)109.7× | | Sales (TTM)$64.39B | | Earnings (TTM)$6.31B | | Net margin6.9% | | ROIC16.0% | | EPS growth 3Y−29.1% | | Sales growth 3Y1.8% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+18.3% | | 1Y+32.1% | | 3Y+95.1% | | 5Y+169.1% | | 10Y+493.4% | | Since incept. (ann.)+20.6% |
Total return · from 2012-12-10ⓘ Risk | Ann. volatility (1Y)26.4% | | Ann. volatility (3Y)24.6% | | Sharpe (1Y)1.19 | | Sharpe (3Y)1.04 | | Max drawdown (1Y)−17.3% | | Max drawdown (3Y)−20.7% | | Beta (3Y vs SPY)0.11 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| BlackRock, Inc. | 150.7M | $32.8B | 8.52% | −0.3% | | VANGUARD CAPITAL MANAGEMENT LLC | 114.9M | $25.0B | 6.50% | new | | STATE STREET CORP | 81.2M | $17.7B | 4.59% | +0.3% | | JPMORGAN CHASE & CO | 56.7M | $12.1B | 3.21% | +8.3% | | VANGUARD PORTFOLIO MANAGEMENT LLC | 49.5M | $10.8B | 2.80% | new | | GEODE CAPITAL MANAGEMENT, LLC | 46.7M | $10.1B | 2.64% | +4.7% | | MORGAN STANLEY | 38.0M | $8.3B | 2.15% | −5.1% | | Capital Research Global Investors | 31.3M | $6.8B | 1.77% | +23.0% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-07-31 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-07-31 | $2.03 | +290.4% | $16.99B | +10.2% | | 2026-03-31 | 2026-04-29 | $0.39 | −45.8% | $15.00B | +12.4% | | 2025-12-31 | 2026-02-04 | $1.02 | — | $16.62B | +10.0% | | 2025-09-30 | 2025-10-31 | $0.10 | −88.6% | $15.78B | +9.1% |
As-reported XBRL · next 2026-11-01 est.ⓘ Segment mixFY2025 (ended Dec 2025) US 76% · Other Countries 9% · DE 3% · JP 2% · CA 2% geographic · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
